OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Cancer Research and Clinical Oncology is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma	88
Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning	86
Estimating the global burden of Epstein–Barr virus-related cancers	81
Role of lung and gut microbiota on lung cancer pathogenesis	73
Artificial intelligence in gastric cancer: a systematic review	65
Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review	63
The function of Piezo1 in colon cancer metastasis and its potential regulatory mechanism	61
Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients	55
Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study	53
Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy	52
Cannabinoids in the landscape of cancer	49
Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters	47
Gut microbiota-derived metabolites in CRC progression and causation	43
Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression	41
Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer	40
Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells	37
Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients	35
Oncology services in corona times: a flash interview among German cancer patients and their physicians	35
Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes	35
Radiomics MRI for lymph node status prediction in breast cancer patients: the state of art	33
Cancer patients’ perspective on shared decision-making and decision aids in oncology	33
3D tumor angiogenesis models: recent advances and challenges	32
Targeting tumor vascularization: promising strategies for vascular normalization	30
Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma	30
Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma	30

A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression	30
Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT	29
Implications of flavonoids as potential modulators of cancer neovascularity	29
CD36: an emerging therapeutic target for cancer and its molecular mechanisms	29
Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials	29
Non-small cell lung cancer patients with ex19del or exon 21 L858R mutation: distinct mechanisms, different efficacies to treatments	29
Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observati	29
High Wilms’ tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA	29